Change to section 5.1 - Pharmacodynamic properties

Change to section 6.3 - Shelf life

smpc Anbesol Adult Strength Gel

lidocaine hydrochloride, chlorocresol, cetylpyridinium chloride

Alliance Pharmaceuticals

Updated 19-Jul-18

Document history

Change to section 4.4 - Special warnings and precautions for use

Change to section 4.9 - Overdose

pil Arthrotec 75 Tablets

misoprostol, diclofenac sodium

Pfizer Limited

Updated 19-Jul-18

Document history

Change to section 2 - pregnancy, breast feeding and fertility

Change to section 2 - what you need to know - contraindications

Change to section 2 - what you need to know - warnings and precautions

Change to section 4 - possible side effects

Change to section 6 - date of revision

pil Hepatyrix

hepatitis a vaccine, typhoid vaccine

GlaxoSmithKline UK

Retired 19-Jul-18

Product/presentation discontinued

smpc Hepatyrix

hepatitis a vaccine, typhoid vaccine

GlaxoSmithKline UK

Retired 19-Jul-18

Product/presentation discontinued

smpc Imnovid 1mg

pomalidomide

Celgene Ltd

Updated 19-Jul-18

Document history

Change to section 10 - Date of revision of the text

Change to section 4.4 - Special warnings and precautions for use

smpc Pharmaton Vitality Capsules

vitamins, minerals, ginseng

SANOFI

Updated 19-Jul-18

Document history

Change to section 10 - Date of revision of the text

Change to section 4.8 - Undesirable effects

pil Curatoderm Lotion

tacalcitol monohydrate

Almirall Limited

Updated 19-Jul-18

Document history

Change to section 1 - what the product is

Change to section 1 - what the product is used for

Change to section 2 - driving and using machines

Change to section 2 - use in children/adolescents

Change to section 2 - what you need to know - contraindications

Change to section 3 - dose and frequency

Change to section 4 - how to report a side effect

Change to section 4 - possible side effects

Change to section 5 - how to store or dispose

Change to section 6 - what the product contains

Improved presentation of PIL

pil Boots Cold and Flu Relief with Ibuprofen

ibuprofen, pseudoephedrine hydrochloride

THE BOOTS COMPANY PLC

Updated 19-Jul-18

Document history

Change to section 2 - what you need to know - warnings and precautions

Change to section 4 - possible side effects

Change to section 6 - date of revision

pil Anbesol Adult Strength Gel

lidocaine hydrochloride, chlorocresol, cetylpyridinium chloride

Alliance Pharmaceuticals

Updated 19-Jul-18

Document history

Change to section 2 - use in children/adolescents

Change to section 5 - how to store or dispose

smpc Simple Linctus Sugar Free

citric acid monohydrate

Pinewood Healthcare

Updated 19-Jul-18

Document history

Change to section 4.8 - Undesirable effects - how to report a side effect

pil Simple Linctus Sugar Free

citric acid monohydrate

Pinewood Healthcare

Updated 19-Jul-18

Document history

Change to section 4 - how to report a side effect

Change to section 6 - manufacturer

pil Solpadeine Plus Tablets

paracetamol, caffeine, codeine phosphate hemihydrate

Omega Pharma Ltd

Updated 19-Jul-18

Document history

Change to section 2 - use in children/adolescents

Change to section 2 - what you need to know - contraindications

Change to section 4 - possible side effects

Change to section 6 - date of revision

Change to section 4.8 - Undesirable effects - how to report a side effect

Change to section 1 - Name of the medicinal product

Change to section 10 - Date of revision of the text

Change to section 2 - Qualitative and quantitative composition

Change to section 3 - Pharmaceutical form

Change to section 4.4 - Special warnings and precautions for use

Change to section 4.8 - Undesirable effects - how to report a side effect

Change to section 6.3 - Shelf life

Change to section 6.5 - Nature and contents of container

Change to section 6.6 - Special precautions for disposal and other handling

Change to section 4 - how to report a side effect

Change to section 6 - manufacturer

Change to section 6.3 - Shelf life

Change to section 6.3 - Shelf life

Change to section 6.3 - Shelf life

Change to section 6.3 - Shelf life

Change to section 10 - Date of revision of the text

Change to section 2 - Qualitative and quantitative composition

Change to section 4.1 - Therapeutic indications

Change to section 4.2 - Posology and method of administration

Change to section 4.3 - Contraindications

Change to section 4.4 - Special warnings and precautions for use

Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Change to section 4.8 - Undesirable effects - how to report a side effect

Change to section 4.9 - Overdose

Change to section 5.1 - Pharmacodynamic properties

Change to section 5.2 - Pharmacokinetic properties

Change to section 10 - Date of revision of the text

Change to section 4.2 - Posology and method of administration

Change to name of medicinal product

Change to section 2 - excipient warnings

Change to section 4 - how to report a side effect

Change to section 6 - what the product looks like and pack contents

Change to section 4.1 - Therapeutic indications

smpc DuoResp Spiromax 320 micrograms/9 micrograms inhalation powder

budesonide, formoterol fumarate dihydrate

Teva Pharma B.V.

Updated 19-Jul-18

Document history

Change to section 4.1 - Therapeutic indications

smpc Solpadeine Plus Tablets

paracetamol, caffeine, codeine phosphate hemihydrate

Omega Pharma Ltd

Updated 19-Jul-18

Document history

Change to section 10 - Date of revision of the text

Change to section 3 - Pharmaceutical form

pil Aricept Tablets

donepezil hydrochloride

Eisai Ltd

Updated 19-Jul-18

Document history

Change to section 3 - overdose, missed or forgotten doses

Change to section 4 - possible side effects

Change to section 6 - date of revision

pil Aricept Evess

donepezil hydrochloride

Eisai Ltd

Updated 19-Jul-18

Document history

Change to section 3 - overdose, missed or forgotten doses

Change to section 4 - possible side effects

Change to section 6 - date of revision

Change to section 4 - how to report a side effect

Change to section 4 - possible side effects

Change to section 6 - date of revision

Change to section 5 - how to store or dispose

Change to section 4 - possible side effects

Change to section 6 - date of revision

Change to section 4 - possible side effects

Change to section 6 - date of revision

Change to section 5 - how to store or dispose

Change to section 4.8 - Undesirable effects - how to report a side effect

Improved presentation of SPC

smpc Maxalt 5mg Tablets

rizatriptan benzoate

Merck Sharp & Dohme Limited

Updated 19-Jul-18

Document history

Change to section 4.8 - Undesirable effects - how to report a side effect

Improved presentation of SPC

smpc Maxalt 10mg Tablets

rizatriptan benzoate

Merck Sharp & Dohme Limited

Updated 19-Jul-18

Document history

Change to section 4.8 - Undesirable effects - how to report a side effect

Improved presentation of SPC

Change to section 1 - Name of the medicinal product

Change to section 10 - Date of revision of the text

Change to section 4.8 - Undesirable effects - how to report a side effect

pil Alu-Cap Capsules

aluminium hydroxide

Meda Pharmaceuticals

Updated 19-Jul-18

Document history

Change to section 6 - date of revision

Change to section 6 - marketing authorisation holder

pil Alu-cap Capsules (POM)

aluminium hydroxide

Meda Pharmaceuticals

Updated 19-Jul-18

Document history

Change to section 6 - date of revision

Change to section 6 - marketing authorisation holder

Change to section 4 - how to report a side effect

Improved presentation of PIL

Change to section 4.2 - Posology and method of administration

Change to section 4.6 - Fertility, pregnancy and lactation

Change to section 4.8 - Undesirable effects

Change to section 6.5 - Nature and contents of container

Change to section 6.5 - Nature and contents of container

pil Maxalt 5mg Tablets

rizatriptan benzoate

Merck Sharp & Dohme Limited

Updated 18-Jul-18

Document history

Change to section 4 - how to report a side effect

Improved presentation of PIL

pil Maxalt 10mg Tablets

rizatriptan benzoate

Merck Sharp & Dohme Limited

Updated 18-Jul-18

Document history

Change to section 4 - how to report a side effect

Improved presentation of PIL

Change to section 10 - Date of revision of the text

Change to section 4.4 - Special warnings and precautions for use

Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Change to section 4.8 - Undesirable effects

pil Qvar Autohaler 100 micrograms

beclometasone dipropionate

Teva UK Limited

Updated 18-Jul-18

Document history

Change to section 6 - manufacturer

pil Qvar Autohaler 50 micrograms

beclometasone dipropionate

Teva UK Limited

Updated 18-Jul-18

Document history

Change to section 6 - manufacturer

Change to section 10 - Date of revision of the text

Change to section 4.4 - Special warnings and precautions for use

Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Change to section 4.8 - Undesirable effects